•Switching standard dosed intravenous to subcutaneous infliximab leads to similar drug exposure in inflammatory bowel disease patients independent of concomitant immunosuppressants (SHUFFLE study)
•Current practices and unmet needs in the management of Clostridioides difficile infection in pediatric inflammatory bowel disease: A national survey
•COMPARATIVE REAL-WORLD EFFECTIVENESS OF BIOLOGIC THERAPIES FOR PREVENTING POSTOPERATIVE ENDOSCOPIC RECURRENCE OF CROHN'S DISEASE
•Is there a difference in the outcomes of long-term seton placement for complex anal fistula in patients with and without Crohn's disease?
•Cellular crosstalk of fibroblast-myofibroblast transition in intestinal homeostasis and disease
